FFCP PHASE2:Hg19::chr10:30132220..30132231,-
From FANTOM5_SSTAR
Revision as of 13:04, 23 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p@chr10:30132220..30132231, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr10:30132220..30132231, - |
| Coexpression cluster: | C48_smooth_bladder_esophagus_colon_penis_aorta_uterus |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr10:30132220..30132231- |
|---|
0
1
2
3
4
5
6
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| vas deferens | 3.61e-34 | 1 |
| spermatic cord | 3.61e-34 | 1 |
| urinary bladder | 6.48e-18 | 2 |
| lower urinary tract | 6.48e-18 | 2 |
| male genital duct | 2.31e-12 | 3 |
| internal male genitalia | 2.31e-12 | 3 |
| esophagus | 3.24e-12 | 3 |
| esophageal region | 3.24e-12 | 3 |
| adult organism | 7.60e-11 | 114 |
| cloaca | 1.90e-10 | 14 |
Showing 1 to 10 of 20 entries
| Ontology term | p-value | n |
|---|---|---|
| heart disease | 9.07e-18 | 2 |
| cardiovascular system disease | 1.44e-09 | 4 |
Showing 1 to 2 of 2 entries
